Navigation Links
UCLA scientists uncover mechanism of response to targeted therapy

Previous studies also had shown that inhibitors of mTOR also might inhibit HIF.

"We theorized that by inhibiting mTOR, which contributes to HIF levels, we might be able to significantly reduce HIF and remove the growth advantage the cancer cells had," Thomas said. "Because we now know the mechanism that is fueling the growth of the cancer cells, we can identify patients who will respond to this drug."

About 50 to 70 percent of kidney cancer patients have lost VHL, Thomas said. Their tumors, therefore, will have high levels of HIF and likely will respond to the drug. This finding could potentially help about 20,000 kidney cancer patients every year.

Typically, scientists seeking a target for a new cancer therapy start work in cell lines andthen advance to laboratory animals to test their theories. Working backward from responsesin clinical trials is unusual, Thomas said. Responses observed in clinical studies led researchers back to the laboratory. Their laboratory findings will be tested in further clinical studies, bringing the observation full circle, from the patient to the lab and back to the patient again.

In this case, CCI-779 was being tested at UCLA in a Phase I study on patients with a variety of advanced cancers. Researchers noted that patients with kidney cancer seemed to respond better to the drug than patients with other cancer types. That led to a Phase II study solely in kidney cancer patients. That study showed that a subset of patients had a complete response, while a high percentage experienced partial responses or had their disease stabilize, meaning it was no longer growing.

Thomas predicted that CCI-779 would probably be most effective when given in combination with other therapies because it "in kidney cancer, it stops the tumor cells from growing, it doesn't kill them." It could be paired with conventional chemotherapy or with another targeted therapy, such as an angiogenesis inhibitor, which cuts o
'"/>

Source:University of California - Los Angeles


Page: 1 2 3

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery
Post Your Comments:
(Date:12/16/2009)... PALM HARBOR, Fla., Dec. 2 ... CICI), a leading supplier of electronic signature ... financial industry* and the recognized leader** in ... ("Docubase"), a leading International Electronic Document Management ... have entered an agreement to provide their ...
(Date:12/16/2009)... Solutions Inc. is pleased to announce it has ... previously operating as IgeaCare Systems Inc. The newly ... new leadership and funding. ,, IgeaCare Solutions Inc. ... of Chief Executive Officer. Under his direction, the ... servicing and support model; fast and accurate delivery ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... identification solutions, today announced that SC Magazine, ... publications, named BIO-key International the 2009 Innovator ... sub-category Biometrics. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ... editor, SC Magazine, "Biometric providers have been ...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 51132 1Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 51132 2Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 51132 3Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 51132 4Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 51132 5Greater Language Skills in 20s May Guard Against Alzheimers 51128 1Greater Language Skills in 20s May Guard Against Alzheimers 51128 2Greater Language Skills in 20s May Guard Against Alzheimers 51128 3Mothers of children with autism have higher parental stress psychological distress 51125 1Mothers of children with autism have higher parental stress psychological distress 51125 2Mothers of children with autism have higher parental stress psychological distress 51125 3
... CAMBRIDGE, Mass. (March 26, 2009) The Howard Hughes ... an Early Career Scientist appointment, a six-year funded position ... , "I am thrilled to receive the HHMI Early ... remarkable history of supporting innovative and creative science, and ...
... MARCH 2009 More than 120 researchers will speak ... life sciences conference to be organized by the European ... 29 August to 1 September 2009. , The ... programmes reflecting the concepts and high-resolution approaches of modern ...
... is available in Spanish . , ... of psychosis and schizophrenia, and those episodes of psychosis ... characteristics, both before their appearance and in the clinical ... conclusions of the doctoral thesis "Neurodevelopment and environmental stress ...
Other Biology News:Whitehead member Peter Reddien named HHMI Early Career Scientist 2Call for abstracts and registration for the EMBO Meeting 2009 2Daily consumption of cannabis predisposes to the appearance of psychosis and schizophrenia 2
(Date:12/16/2009)... -- Capitalizing on the continued strong growth ... venture capital market, leaders from BioCrossroads, Eli Lilly ... University, Purdue University, the University of Notre Dame, ... announced the establishment of the INext Fund, a ... Organized through BioCrossroads, Indiana,s initiative to grow, expand ...
(Date:12/16/2009)... biotechnology company,s revenues increase 22% for fiscal 2009; ... 2010 , TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix ... virology and biological technologies, today reported financial results ... fiscal year ended September 30, 2009, Microbix reported ... the same period in 2008. For fourth-quarter 2009, ...
(Date:12/16/2009)... Protocol Assessment with the Food and Drug ... - AEterna Zentaris Inc. (NASDAQ: AEZS ... biopharmaceutical company focused on oncology and endocrine ... partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), ... for perifosine (KRX-0401), the Company,s PI3K/Akt pathway ...
(Date:12/16/2009)... 16 Eppendorf has initiated an,import ... SP systems for,infringement of European patent EP ... the,identification and/or the quantification of a target ... imports of the respective products into any ... required to confiscate any,violating products. , ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2
... Aug. 5 Orexigen(R) Therapeutics,Inc. (Nasdaq: OREX ), ... system disorders, including obesity, will announce,financial results for its ... 2008, after the markets close. The announcement will be ... p.m. Pacific Time., Orexigen management will host the ...
... Innovations Inc.,(TSX: ATB), a recognized leading developer, manufacturer ... the health and,nutrition industries, today announced that its ... present a company overview,at the upcoming 28th Annual ... 2008 at 11 am (eastern time), in the ...
... NGSX ), a biopharmaceutical company focused on developing ... results for its second quarter 2008 on Wednesday, August ... to review the results will begin at 4:30 p.m. ... be hosted by Anthony DiTonno,President and Chief Executive Officer, ...
Other Biology Technology:Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008 2NeurogesX to Report Second Quarter 2008 Financial Results 2NeurogesX to Report Second Quarter 2008 Financial Results 3
Ras-related C3 botulinum toxin substrate 1...
Human sVCAM-1/CD106 ELI-PAIR Kit...
HP 1 alpha Immunogen: Synthetic peptide between amino acids 1-100 of the human HP 1 alpha protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... gene in baculoviral expression vector, transfection ... purification of ten clones, generation of ... clone, protein expression and tag purification ... yield and timeline: 1-4 mg of ...
Biology Products: